Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents

被引:0
作者
Markus R. Meyer
Hans H. Maurer
机构
[1] Saarland University,Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology
来源
Analytical and Bioanalytical Chemistry | 2012年 / 402卷
关键词
Drugs of abuse; Doping; Mass spectrometry; Liquid chromatography; Gas chromatography; Metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
This paper reviews scientific contributions on the identification and/or quantification of metabolites of drugs of abuse in in vitro assays or various body samples using hyphenated mass spectrometry. Gas chromatography–mass spectrometry (GC-MS) as well as liquid chromatography–mass spectrometry (LC-MS) approaches are considered and discussed if they have been reported in the last five years and are relevant to clinical and forensic toxicology or doping control. Workup and artifact formation are discussed, and typical examples of studies of the metabolism of designer drugs, doping agents, herbal drugs, and synthetic cannabinoids are provided. Procedures for quantifying metabolites in body samples for pharmacokinetic studies or in enzyme incubations for enzyme kinetic studies are also reviewed. In conclusion, the reviewed papers showed that both GC-MS and LC-MS still have important roles to play in research into the metabolism of drugs of abuse, including doping agents.
引用
收藏
页码:195 / 208
页数:13
相关论文
共 652 条
  • [1] Maurer HH(2010)undefined Ther Drug Monit 32 544-549
  • [2] Meyer MR(2010)undefined Curr Drug Metab 11 468-482
  • [3] Maurer HH(2010)undefined Bioanalysis 2 965-979
  • [4] Wohlfarth A(2009)undefined J Pharm Pharmacol 61 877-882
  • [5] Weinmann W(2009)undefined Arch Toxicol 83 69-80
  • [6] Antia U(2005)undefined Forensic Sci Int 153 85-91
  • [7] Tingle MD(2004)undefined Australas Psychiatry 12 406-408
  • [8] Russell BR(2004)undefined Ther Drug Monit 26 127-131
  • [9] Nakagawa Y(2001)undefined Can Med Assoc J 165 917-928
  • [10] Suzuki T(2009)undefined Drug Metab Dispos 37 2079-2086